CB Scientific, Inc. (OTCPK:CBSC) entered into an agreement to acquire Datrix, LLC for $2.1 million on October 26, 2020. Under the terms of the consideration, the transaction will be settled through cash payment of $1.5 million and issuance of 0.48 million CB restricted common stock. Datrix will continue to operate as an OEM manufacturer to its existing customer base. The transaction is subject to customary closing conditions and is expected to close during Q4 of fiscal year 2020. As of February 22, 2021 the transaction is expected to close in April, 2021.